Thus, mGluR5 PAMs may be of potential utility as pharmacological adjuncts to cue exposure therapy in the treatment of drug addiction, and may potentially reverse certain cognitive deficits associated with heavy drug use. This evidence concerns the gene GRM5 and Cognitive impairment.